Table 2 Previous reports on cyclins D2 and D3 expression by immunohistochemistry in DLBCLs
From: De novo CD5-positive diffuse large B-cell lymphomas show high specificity for cyclin D2 expression
Reference (reference no.) | No. of patients | Cut-off line (%) | Positive cases (%) | ||
|---|---|---|---|---|---|
Cyclin D2 | Cyclin D3 | ||||
Hans CP, et al., 2004[8] | 152 | 30 | 13 | ND | |
Hans CP, et al., 2005[9] | 200 | 30 | 19 | 62 | |
Amen F, et al., 2007[10] | 80 | 10 | 25 | ND | |
Metcalf RA, et al., 2010[3] | 194 | 20 | 49 | 20 | |
Present study CD5+ DLBCLs | 51 | 20 | 98 | 35 | |
        CD5− DLBCLs | 51 | 20 | 28 | 47 | |